Menopause Clinical Trial
Official title:
Safety Profile and Bone Efficacy of the Phytoestrogen Genistein in a Cohort of Osteopenic, Postmenopausal Women After Three Years of Treatment: a Follow-up Study
BACKGROUND: Recent evidences showed that the phytoestrogen genistein positively affects bone
metabolism with no clinically significant adverse effects in a cohort of osteopenic,
postmenopausal women. However, there is still a knowledge gap regarding the long-term safety
of genistein on the breast, the uterus, the thyroid gland and its efficacy in postmenopausal
women.
OBJECTIVE: To assess the safety profile of genistein on mammary and thyroid glands and
endometrium and cardiovascular apparatus and its effects on bone metabolism after a 3-year
therapy with pure, standardized genistein (54 mg/day).
DESIGN: The parent study was a randomized, double-blind, placebo-controlled trial involving
389 osteopenic, postmenopausal women for 24 months. After the 24-month visit, a
sub-population (138 patients) accepted to continue the intervention until 36 months, thus
generating a follow-up study.
SETTING: 3 Italian university medical centers. INTERVENTIONS: Participants received 54 mg of
genistein, daily, (n=71) or placebo (n=67). Both intervention and placebo contained calcium
and vitamin D3. All patients also received dietary instruction in an isocaloric fat-reduced
diet.
MEASUREMENTS: Mammographic breast density at baseline and after 24 and 36 months was
assessed by visual classification scale and by digitized quantification. BRCA1 and BRCA2
molecular message, sister chromatid exchanges and endometrial thickness were also evaluated
at the same time points. Measurements of lumbar spine and femoral neck BMD and QUS t-score
were assayed in our patients. Secondary outcomes were serum levels of B-ALP, IGF-I, sRANKL,
osteoprotegerin and urinary excretion of CTX, pyridinoline and deoxypyridinoline.
Furthermore insulin resistance (HOMA-IR), glucose levels, homocysteine and hot flushes were
also evaluated. In addition for thyroid safety TSH, fT3, fT4, thyroid autoantibodies, and
mRNA for thyroid and retinoid receptors were evaluated.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04553029 -
A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)
|
||
Completed |
NCT03672513 -
Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause
|
N/A | |
Terminated |
NCT03642119 -
Validation of an Objective Instrument to Measure Hot Flashes During Menopause
|
||
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04210583 -
RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Completed |
NCT05617287 -
An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause
|
N/A | |
Recruiting |
NCT05180266 -
Therapeutic Touch and Music in The Menopausal Period
|
N/A | |
Recruiting |
NCT04043520 -
Bioenergetic Effects of Aging and Menopause (BEAM)
|
Phase 4 | |
Completed |
NCT03663075 -
Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women
|
N/A | |
Completed |
NCT03363997 -
Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days
|
Phase 1 | |
Not yet recruiting |
NCT04724135 -
Assessment of Menopause Related Quality of Life Among Health Professionals in University Hospitals of UMC in Nur-Sultan
|
||
Not yet recruiting |
NCT04728126 -
Menopausal Symptoms and Burnout: Comparison of Occupational Health Issue Among Health Professionals in UMC Hospitals
|
||
Completed |
NCT02274571 -
Raising Insulin Sensitivity in Post Menopause
|
Early Phase 1 | |
Completed |
NCT02253173 -
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
|
Phase 3 | |
Completed |
NCT02430987 -
Low Sexual Desire and Metabolic Syndrome
|
N/A | |
Completed |
NCT01757340 -
Calorie Restriction With Leucine Supplementation
|
N/A | |
Recruiting |
NCT01488903 -
A Cohort Research of Genetic Susceptibility for Common Obesity in Women
|
N/A | |
Terminated |
NCT01633814 -
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
|
N/A | |
Completed |
NCT00599456 -
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
|
N/A |